- Home
- KELYB vs AURA Comparison
KELYB vs AURA Comparison
Compare KELYB & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KELYB
- AURA
- Stock Information
- Founded
- KELYB 1946
- AURA 2007
- Country
- KELYB United States
- AURA United States
- Employees
- KELYB N/A
- AURA N/A
- Industry
- KELYB Professional Services
- AURA Biotechnology: Pharmaceutical Preparations
- Sector
- KELYB Consumer Discretionary
- AURA Health Care
- Exchange
- KELYB Nasdaq
- AURA Nasdaq
- Market Cap
- KELYB 426.3M
- AURA 396.8M
- IPO Year
- KELYB N/A
- AURA 2021
- Fundamental
- Price
- KELYB $12.11
- AURA $6.29
- Analyst Decision
- KELYB
- AURA Strong Buy
- Analyst Count
- KELYB 0
- AURA 6
- Target Price
- KELYB N/A
- AURA $22.33
- AVG Volume (30 Days)
- KELYB 195.0
- AURA 195.0K
- Earning Date
- KELYB 08-07-2025
- AURA 08-07-2025
- Dividend Yield
- KELYB 2.60%
- AURA N/A
- EPS Growth
- KELYB N/A
- AURA N/A
- EPS
- KELYB N/A
- AURA N/A
- Revenue
- KELYB $4,451,600,000.00
- AURA N/A
- Revenue This Year
- KELYB $8.06
- AURA N/A
- Revenue Next Year
- KELYB $4.08
- AURA N/A
- P/E Ratio
- KELYB N/A
- AURA N/A
- Revenue Growth
- KELYB N/A
- AURA N/A
- 52 Week Low
- KELYB $11.04
- AURA $4.35
- 52 Week High
- KELYB $22.98
- AURA $12.38
- Technical
- Relative Strength Index (RSI)
- KELYB 65.04
- AURA 51.56
- Support Level
- KELYB $11.30
- AURA $5.92
- Resistance Level
- KELYB $12.60
- AURA $6.68
- Average True Range (ATR)
- KELYB 0.04
- AURA 0.41
- MACD
- KELYB 0.09
- AURA -0.02
- Stochastic Oscillator
- KELYB 57.76
- AURA 30.83
About KELYB Kelly Services Inc. Class B
Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.